Fibromyalgia: Diagnosis and Management.

Area of Science:

• Rheumatology
• Pain Medicine
• Clinical Therapeutics

Background:

• Fibromyalgia is a chronic, centralized pain syndrome affecting approximately 2% of the US population, predominantly women.
• Characterized by widespread pain, fatigue, sleep disturbances, cognitive issues, and mood disorders.
• Comorbidities like functional somatic syndromes and psychiatric diagnoses are common.

Purpose of the Study:

• To provide an overview of fibromyalgia diagnosis and management.
• To highlight effective screening tools and diagnostic criteria.
• To discuss optimal therapeutic strategies for fibromyalgia.

Main Methods:

• Review of diagnostic criteria including the Fibromyalgia Rapid Screening Tool, American College of Rheumatology criteria, and ACR/P4 Pain Taxonomy.
• Discussion of nonpharmacologic and pharmacologic treatment options.
• Evaluation of medication efficacy and limitations.

Main Results:

• Fibromyalgia screening tools and established criteria aid in diagnosis.
• Multidisciplinary approaches incorporating nonpharmacologic therapies (education, exercise, CBT) improve pain and function.
• Specific medications like duloxetine, milnacipran, pregabalin, and amitriptyline show potential efficacy.

Conclusions:

• Accurate diagnosis and patient education are crucial for reassurance and reducing unnecessary tests.
• A multidisciplinary treatment strategy is most effective for managing fibromyalgia symptoms.
• Certain medications are beneficial, while NSAIDs and opioids lack demonstrated benefits and have limitations.